TreeWAS – Variant ID: rs3096696

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D64.9 Anaemia, unspecified	1.000	0.000	0.000
E03.9 Hypothyroidism, unspecified	1.000	0.000	0.000
E05.9 Thyrotoxicosis, unspecified	1.000	0.000	0.000
E05.0 Thyrotoxicosis with diffuse goitre	1.000	0.000	0.000
E10.9 Without complications	1.000	0.000	0.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
E05 Thyrotoxicosis [hyperthyroidism]	1.000	0.000	0.000
E11 Non-insulin-dependent diabetes mellitus	1.000	0.000	0.000
E10 Insulin-dependent diabetes mellitus	1.000	0.000	0.000
L40 Psoriasis	1.000	0.000	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	1.000	0.000	0.000
E10-E14 Diabetes mellitus	1.000	0.000	0.000
E00-E07 Disorders of thyroid gland	1.000	0.000	0.000
G50-G59 Nerve, nerve root and plexus disorders	1.000	0.000	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	1.000	0.000	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	1.000	0.000	0.000
# Top node	1.000	0.000	0.000
R31 Unspecified haematuria	0.000	0.000	1.000
E03 Other hypothyroidism	1.000	0.000	0.000
E11.9 Without complications	1.000	0.000	0.000
L40-L45 Papulosquamous disorders	1.000	0.000	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	1.000	0.000	0.000
G56.0 Carpal tunnel syndrome	1.000	0.000	0.000
Chapter VI Diseases of the nervous system	1.000	0.000	0.000
G56 Mononeuropathies of upper limb	1.000	0.000	0.000
E10.3 With ophthalmic complications	1.000	0.000	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	1.000	0.000	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	1.000	0.000	0.000
D64 Other anaemias	1.000	0.000	0.000
E16 Other disorders of pancreatic internal secretion	1.000	0.000	0.000
Chapter XI Diseases of the digestive system	0.999	0.001	0.000
D60-D64 Aplastic and other anaemias	0.999	0.001	0.000
Chapter II Neoplasms	0.999	0.001	0.000
K70-K77 Diseases of liver	0.999	0.001	0.000
E14 Unspecified diabetes mellitus	0.999	0.001	0.000
E16.2 Hypoglycaemia, unspecified	0.999	0.001	0.000
D70-D77 Other diseases of blood and blood-forming organs	0.999	0.001	0.000
G55 Nerve root and plexus compressions in diseases classified elsewhere	0.999	0.001	0.000
K75 Other inflammatory liver diseases	0.999	0.001	0.000
D70 Agranulocytosis	0.998	0.002	0.000
E20-E35 Disorders of other endocrine glands	0.997	0.003	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.996	0.004	0.000
K75.8 Other specified inflammatory liver diseases	0.995	0.005	0.000
E10.1 With ketoacidosis	0.995	0.005	0.000
K20-K31 Diseases of oesophagus, stomach and duodenum	0.995	0.005	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.994	0.006	0.000
K29 Gastritis and duodenitis	0.994	0.006	0.000
G55.1 Nerve root and plexus compressions in intervertebral disk disorders	0.994	0.006	0.000
K29.5 Chronic gastritis, unspecified	0.993	0.007	0.000
N00-N08 Glomerular diseases	0.993	0.007	0.000
E14.3 With ophthalmic complications	0.992	0.008	0.000
C34 Malignant neoplasm of bronchus and lung	0.990	0.010	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.990	0.010	0.000
E27 Other disorders of adrenal gland	0.990	0.010	0.000
C83.3 Large cell (diffuse)	0.989	0.011	0.000
C85.1 B-cell lymphoma, unspecified	0.987	0.013	0.000
K31 Other diseases of stomach and duodenum	0.987	0.013	0.000
E27.1 Primary adrenocortical insufficiency	0.986	0.014	0.000
N04 Nephrotic syndrome	0.986	0.014	0.000
K31.8 Other specified diseases of stomach and duodenum	0.985	0.015	0.000
N05 Unspecified nephritic syndrome	0.984	0.016	0.000
K29.8 Duodenitis	0.983	0.017	0.000
K75.4 Autoimmune hepatitis	0.982	0.018	0.000
C34.3 Lower lobe, bronchus or lung	0.982	0.018	0.000
C91 Lymphoid leukaemia	0.980	0.020	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.980	0.020	0.000
M05-M14 Inflammatory polyarthropathies	0.623	0.021	0.356
N04.9 Unspecified	0.976	0.024	0.000
Chapter XIV Diseases of the genitourinary system	0.975	0.025	0.000
L50-L54 Urticaria and erythema	0.973	0.027	0.000
G55.3 Nerve root and plexus compressions in other dorsopathies	0.970	0.030	0.000
C15-C26 Malignant neoplasms of digestive organs	0.970	0.030	0.000
L40.0 Psoriasis vulgaris	0.970	0.030	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.969	0.031	0.000
K73 Chronic hepatitis, not elsewhere classified	0.968	0.032	0.000
G51 Facial nerve disorders	0.965	0.035	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.964	0.036	0.000
N17-N19 Renal failure	0.962	0.038	0.000
N18 Chronic renal failure	0.961	0.039	0.000
C20 Malignant neoplasm of rectum	0.960	0.040	0.000
N05.2 Diffuse membranous glomerulonephritis	0.958	0.042	0.000
C91.1 Chronic lymphocytic leukaemia	0.955	0.045	0.000
K29.7 Gastritis, unspecified	0.953	0.047	0.000
E10.2 With renal complications	0.953	0.047	0.000
E13 Other specified diabetes mellitus	0.952	0.048	0.000
L10-L14 Bullous disorders	0.948	0.052	0.000
N18.9 Chronic renal failure, unspecified	0.946	0.054	0.000
K90-K93 Other diseases of the digestive system	0.943	0.057	0.000
K90 Intestinal malabsorption	0.940	0.060	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.940	0.060	0.000
K31.9 Disease of stomach and duodenum, unspecified	0.936	0.064	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.934	0.066	0.000
K90.9 Intestinal malabsorption, unspecified	0.933	0.067	0.000
D80-D89 Certain disorders involving the immune mechanism	0.931	0.069	0.000
M06.9 Rheumatoid arthritis, unspecified	0.000	0.074	0.926
L52 Erythema nodosum	0.926	0.074	0.000
E14.8 With unspecified complications	0.925	0.075	0.000
M06 Other rheumatoid arthritis	0.014	0.080	0.906
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.081	0.919
E11.5 With peripheral circulatory complications	0.918	0.082	0.000
E13.9 Without complications	0.917	0.083	0.000
L13 Other bullous disorders	0.916	0.084	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.914	0.086	0.000
G51.0 Bell's palsy	0.913	0.087	0.000
K25 Gastric ulcer	0.912	0.088	0.000
E11.3 With ophthalmic complications	0.907	0.093	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.904	0.096	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.102	0.898
Q38-Q45 Other congenital malformations of the digestive system	0.897	0.103	0.000
M07.3 Other psoriatic arthropathies	0.893	0.104	0.003
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.895	0.105	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.894	0.106	0.000
L13.0 Dermatitis herpetiformis	0.893	0.107	0.000
G70-G73 Diseases of myoneural junction and muscle	0.889	0.111	0.000
Chapter XX External causes of morbidity and mortality	0.888	0.112	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.887	0.113	0.000
M07 Psoriatic and enteropathic arthropathies	0.736	0.114	0.150
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.885	0.115	0.000
K73.9 Chronic hepatitis, unspecified	0.883	0.117	0.000
G51.9 Disorder of facial nerve, unspecified	0.882	0.118	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.881	0.119	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.880	0.120	0.000
E11.2 With renal complications	0.877	0.123	0.000
M06.3 Rheumatoid nodule	0.006	0.124	0.870
Y42.7 Androgens and anabolic congeners	0.875	0.125	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.874	0.126	0.000
C23 Malignant neoplasm of gallbladder	0.871	0.129	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.867	0.133	0.000
L50 Urticaria	0.867	0.133	0.000
E24 Cushing's syndrome	0.864	0.136	0.000
N05.1 Focal and segmental glomerular lesions	0.863	0.137	0.000
G00 Bacterial meningitis, not elsewhere classified	0.861	0.139	0.000
D72 Other disorders of white blood cells	0.861	0.139	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.860	0.140	0.000
C34.2 Middle lobe, bronchus or lung	0.860	0.140	0.000
E14.9 Without complications	0.859	0.141	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.859	0.141	0.000
L40.1 Generalised pustular psoriasis	0.859	0.141	0.000
N18.3 Chronic kidney disease, stage 3	0.857	0.143	0.000
E11.6 With other specified complications	0.856	0.144	0.000
K50-K52 Noninfective enteritis and colitis	0.824	0.145	0.031
D55-D59 Haemolytic anaemias	0.852	0.148	0.000
N18.0 End-stage renal disease	0.851	0.149	0.000
E10.4 With neurological complications	0.850	0.150	0.000
M06.34 Rheumatoid nodule (Hand)	0.001	0.151	0.848
N18.4 Chronic kidney disease, stage 4	0.848	0.152	0.000
G59 Mononeuropathy in diseases classified elsewhere	0.848	0.152	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.848	0.152	0.000
L43 Lichen planus	0.847	0.153	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.845	0.155	0.000
D80 Immunodeficiency with predominantly antibody defects	0.843	0.157	0.000
E11.1 With ketoacidosis	0.840	0.160	0.000
C92 Myeloid leukaemia	0.839	0.161	0.000
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.837	0.163	0.000
G30-G32 Other degenerative diseases of the nervous system	0.836	0.164	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.165	0.835
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.834	0.166	0.000
E50-E64 Other nutritional deficiencies	0.834	0.166	0.000
Q50-Q56 Congenital malformations of genital organs	0.828	0.172	0.000
K74 Fibrosis and cirrhosis of liver	0.827	0.173	0.000
Y43 Primarily systemic agents	0.827	0.173	0.000
Q60-Q64 Congenital malformations of the urinary system	0.826	0.173	0.000
M06.0 Seronegative rheumatoid arthritis	0.004	0.174	0.821
W20-W49 Exposure to inanimate mechanical forces	0.825	0.175	0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.825	0.175	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.824	0.176	0.000
C34.8 Overlapping lesion of bronchus and lung	0.824	0.176	0.000
Chapter I Certain infectious and parasitic diseases	0.824	0.176	0.000
E03.8 Other specified hypothyroidism	0.822	0.177	0.000
G56.4 Causalgia	0.820	0.180	0.000
L44 Other papulosquamous disorders	0.819	0.181	0.000
C91.0 Acute lymphoblastic leukaemia	0.815	0.185	0.000
D73 Diseases of spleen	0.814	0.186	0.000
K52 Other non-infective gastro-enteritis and colitis	0.810	0.187	0.003
E28 Ovarian dysfunction	0.812	0.188	0.000
Y42.2 Antithyroid drugs	0.812	0.188	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.812	0.188	0.000
G62 Other polyneuropathies	0.811	0.189	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.810	0.190	0.000
C34.0 Main bronchus	0.809	0.191	0.000
D72.8 Other specified disorders of white blood cells	0.808	0.192	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.807	0.193	0.000
N04.2 Diffuse membranous glomerulonephritis	0.800	0.200	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.799	0.201	0.000
E14.5 With peripheral circulatory complications	0.797	0.203	0.000
E10.0 With coma	0.797	0.203	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.797	0.203	0.000
C22.9 Liver, unspecified	0.797	0.203	0.000
E31 Polyglandular dysfunction	0.795	0.205	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.794	0.206	0.000
C91.9 Lymphoid leukaemia, unspecified	0.794	0.206	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.793	0.207	0.000
C60-C63 Malignant neoplasms of male genital organs	0.790	0.210	0.000
Y43.3 Other antineoplastic drugs	0.789	0.211	0.000
C95 Leukaemia of unspecified cell type	0.788	0.212	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.787	0.213	0.000
M05 Seropositive rheumatoid arthritis	0.309	0.213	0.478
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.786	0.214	0.000
Q80-Q89 Other congenital malformations	0.786	0.214	0.000
E21.3 Hyperparathyroidism, unspecified	0.784	0.215	0.000
N18.2 Chronic kidney disease, stage 2	0.783	0.217	0.000
D86 Sarcoidosis	0.782	0.218	0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.780	0.220	0.000
E14.1 With ketoacidosis	0.779	0.220	0.000
E10.7 With multiple complications	0.779	0.221	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.779	0.221	0.000
G56.1 Other lesions of median nerve	0.779	0.221	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.776	0.224	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.226	0.774
N04.1 Focal and segmental glomerular lesions	0.771	0.229	0.000
L43.9 Lichen planus, unspecified	0.770	0.230	0.000
E24.0 Pituitary-dependent Cushing's disease	0.768	0.232	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.768	0.232	0.000
L40.3 Pustulosis palmaris et plantaris	0.768	0.232	0.000
C38.4 Pleura	0.768	0.232	0.000
B35-B49 Mycoses	0.768	0.232	0.000
E16.1 Other hypoglycaemia	0.768	0.232	0.000
G50 Disorders of trigeminal nerve	0.767	0.233	0.000
K25.3 Acute without haemorrhage or perforation	0.766	0.234	0.000
E10.6 With other specified complications	0.766	0.234	0.000
W22 Striking against or struck by other objects	0.765	0.235	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.764	0.236	0.000
E07 Other disorders of thyroid	0.763	0.237	0.000
G11 Hereditary ataxia	0.761	0.239	0.000
D59 Acquired haemolytic anaemia	0.760	0.240	0.000
C31 Malignant neoplasm of accessory sinuses	0.760	0.240	0.000
C21 Malignant neoplasm of anus and anal canal	0.759	0.241	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.241	0.759
G00.1 Pneumococcal meningitis	0.759	0.241	0.000
L50.0 Allergic urticaria	0.758	0.242	0.000
K74.0 Hepatic fibrosis	0.757	0.243	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.757	0.243	0.000
G62.9 Polyneuropathy, unspecified	0.754	0.246	0.000
G70 Myasthenia gravis and other myoneural disorders	0.753	0.247	0.000
Q30-Q34 Congenital malformations of the respiratory system	0.753	0.247	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.752	0.248	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.752	0.248	0.000
E14.4 With neurological complications	0.751	0.249	0.000
C88 Malignant immunoproliferative diseases	0.750	0.250	0.000
C33 Malignant neoplasm of trachea	0.750	0.250	0.000
E27.2 Addisonian crisis	0.749	0.251	0.000
E21.0 Primary hyperparathyroidism	0.749	0.251	0.000
N05.8 Other	0.748	0.252	0.000
G55.0 Nerve root and plexus compressions in neoplastic disease	0.748	0.252	0.000
Y48 Anaesthetics and therapeutic gases	0.748	0.252	0.000
B25-B34 Other viral diseases	0.747	0.253	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.747	0.253	0.000
Q43 Other congenital malformations of intestine	0.747	0.253	0.000
K71 Toxic liver disease	0.746	0.254	0.000
B37 Candidiasis	0.745	0.255	0.000
C82.2 Large cell, follicular	0.745	0.255	0.000
K25.4 Chronic or unspecified with haemorrhage	0.743	0.257	0.000
L53 Other erythematous conditions	0.743	0.257	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.741	0.258	0.002
G71 Primary disorders of muscles	0.742	0.258	0.000
E14.2 Withrenal complications	0.742	0.258	0.000
E20 Hypoparathyroidism	0.742	0.258	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.742	0.258	0.000
C34.9 Bronchus or lung, unspecified	0.741	0.259	0.000
Q00-Q07 Congenital malformations of the nervous system	0.740	0.260	0.000
E40-E46 Malnutrition	0.740	0.260	0.000
G59.0 Diabetic mononeuropathy	0.739	0.261	0.000
L50.1 Idiopathic urticaria	0.738	0.262	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.737	0.263	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.001	0.263	0.736
D83 Common variable immunodeficiency	0.736	0.264	0.000
G52 Disorders of other cranial nerves	0.736	0.264	0.000
E10.8 With unspecified complications	0.734	0.266	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.266	0.734
M07.34 Other psoriatic arthropathies (Hand)	0.731	0.267	0.002
E03.1 Congenital hypothyroidism without goitre	0.733	0.267	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.023	0.268	0.709
G56.9 Mononeuropathy of upper limb, unspecified	0.730	0.269	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.730	0.270	0.000
B15-B19 Viral hepatitis	0.728	0.272	0.000
G00.9 Bacterial meningitis, unspecified	0.726	0.274	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.725	0.275	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.722	0.278	0.000
E21.2 Other hyperparathyroidism	0.719	0.281	0.000
E23 Hypofunction and other disorders of pituitary gland	0.718	0.282	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.717	0.283	0.000
E05.5 Thyroid crisis or storm	0.717	0.283	0.000
E05.4 Thyrotoxicosis factitia	0.717	0.283	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.717	0.283	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.717	0.283	0.000
E11.7 With multiple complications	0.717	0.283	0.000
L40.4 Guttate psoriasis	0.717	0.283	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.717	0.283	0.000
C94 Other leukaemias of specified cell type	0.717	0.283	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.717	0.283	0.000
E00 Congenital iodine-deficiency syndrome	0.717	0.283	0.000
E12 Malnutrition-related diabetes mellitus	0.717	0.283	0.000
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283	0.000
E03.5 Myxoedema coma	0.717	0.283	0.000
E03.4 Atrophy of thyroid (acquired)	0.717	0.283	0.000
E03.3 Postinfectious hypothyroidism	0.717	0.283	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.717	0.283	0.000
L41 Parapsoriasis	0.717	0.283	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.717	0.283	0.000
C85.0 Lymphosarcoma	0.717	0.283	0.000
E15 Nondiabetic hypoglycaemic coma	0.717	0.283	0.000
D64.4 Congenital dyserythropoietic anaemia	0.717	0.283	0.000
D64.3 Other sideroblastic anaemias	0.717	0.283	0.000
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.717	0.283	0.000
D64.1 Secondary sideroblastic anaemia due to disease	0.717	0.283	0.000
D64.0 Hereditary sideroblastic anaemia	0.717	0.283	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.717	0.283	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.717	0.283	0.000
E16.4 Abnormal secretion of gastrin	0.717	0.283	0.000
E16.3 Increased secretion of glucagon	0.717	0.283	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.001	0.283	0.715
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.717	0.283	0.000
K77 Liver disorders in diseases classified elsewhere	0.716	0.283	0.000
E14.7 With multiple complications	0.716	0.283	0.000
E14.0 With coma	0.716	0.283	0.000
K72 Hepatic failure, not elsewhere classified	0.716	0.284	0.000
D74 Methaemoglobinaemia	0.716	0.284	0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere	0.716	0.284	0.000
D71 Functional disorders of polymorphonuclear neutrophils	0.716	0.284	0.000
K75.2 Nonspecific reactive hepatitis	0.716	0.284	0.000
K75.1 Phlebitis of portal vein	0.716	0.284	0.000
K29.3 Chronic superficial gastritis	0.716	0.284	0.000
G56.2 Lesion of ulnar nerve	0.716	0.284	0.000
X10-X19 Contact with heat and hot substances	0.716	0.284	0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system	0.715	0.285	0.000
K74.6 Other and unspecified cirrhosis of liver	0.715	0.285	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.715	0.285	0.000
E32 Diseases of thymus	0.715	0.285	0.000
E30 Disorders of puberty, not elsewhere classified	0.715	0.285	0.000
E25 Adrenogenital disorders	0.715	0.285	0.000
K29.9 Gastroduodenitis, unspecified	0.713	0.287	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.713	0.287	0.000
G55.8 Nerve root and plexus compressions in other diseases classified elsewhere	0.713	0.287	0.000
G64 Other disorders of peripheral nervous system	0.712	0.288	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.712	0.288	0.000
N06 Isolated proteinuria with specified morphological lesion	0.712	0.288	0.000
N01 Rapidly progressive nephritic syndrome	0.712	0.288	0.000
N00 Acute nephritic syndrome	0.712	0.288	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.711	0.289	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.711	0.289	0.000
C83.6 Undifferentiated (diffuse)	0.710	0.290	0.000
C83.5 Lymphoblastic (diffuse)	0.710	0.290	0.000
C83.4 Immunoblastic (diffuse)	0.710	0.290	0.000
C83.2 Mixed small and large cell (diffuse)	0.710	0.290	0.000
E27.5 Adrenomedullary hyperfunction	0.710	0.290	0.000
E27.0 Other adrenocortical overactivity	0.710	0.290	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.000	0.291	0.708
K25.0 Acute with haemorrhage	0.708	0.292	0.000
K31.6 Fistula of stomach and duodenum	0.707	0.293	0.000
K31.2 Hourglass stricture and stenosis of stomach	0.707	0.293	0.000
K31.0 Acute dilatation of stomach	0.707	0.293	0.000
K27 Peptic ulcer, site unspecified	0.707	0.293	0.000
N04.8 Other	0.707	0.293	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.707	0.293	0.000
N04.6 Dense deposit disease	0.707	0.293	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.707	0.293	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.707	0.293	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.707	0.293	0.000
N04.0 Minor glomerular abnormality	0.707	0.293	0.000
N05.6 Dense deposit disease	0.705	0.295	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.705	0.295	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.705	0.295	0.000
N05.0 Minor glomerular abnormality	0.705	0.295	0.000
G60 Hereditary and idiopathic neuropathy	0.705	0.295	0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.704	0.296	0.000
N25-N29 Other disorders of kidney and ureter	0.703	0.297	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.702	0.297	0.000
C91.7 Other lymphoid leukaemia	0.702	0.297	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.702	0.297	0.000
C91.5 Adult T-cell leukaemia	0.702	0.297	0.000
C91.3 Prolymphocytic leukaemia	0.702	0.297	0.000
C91.2 Subacute lymphocytic leukaemia	0.702	0.297	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.702	0.297	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.702	0.298	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.702	0.298	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.702	0.298	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.702	0.298	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.702	0.298	0.000
C38.3 Mediastinum, part unspecified	0.702	0.298	0.000
M09 Juvenile arthritis in diseases classified elsewhere	0.447	0.298	0.255
M08 Juvenile arthritis	0.447	0.298	0.255
K31.3 Pylorospasm, not elsewhere classified	0.701	0.299	0.000
B90-B94 Sequelae of infectious and parasitic diseases	0.701	0.299	0.000
Chapter XXII Codes for special purposes	0.700	0.300	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.699	0.301	0.000
D50-D53 Nutritional anaemias	0.698	0.302	0.000
C04 Malignant neoplasm of floor of mouth	0.698	0.302	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.696	0.302	0.002
K90.8 Other intestinal malabsorption	0.698	0.302	0.000
L54 Erythema in diseases classified elsewhere	0.697	0.302	0.000
M12 Other specific arthropathies	0.466	0.303	0.232
C62 Malignant neoplasm of testis	0.696	0.303	0.000
C81 Hodgkin's disease	0.696	0.304	0.000
E24.2 Drug-induced Cushing's syndrome	0.695	0.305	0.000
Q35-Q37 Cleft lip and cleft palate	0.695	0.305	0.000
E70-E90 Metabolic disorders	0.695	0.305	0.000
W22.9 Unspecified place	0.694	0.306	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.694	0.306	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.694	0.306	0.000
W50-W64 Exposure to animate mechanical forces	0.694	0.306	0.000
E07.8 Other specified disorders of thyroid	0.692	0.308	0.000
G51.4 Facial myokymia	0.692	0.308	0.000
G51.2 Melkersson's syndrome	0.692	0.308	0.000
G51.1 Geniculate ganglionitis	0.692	0.308	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.692	0.308	0.000
D82 Immunodeficiency associated with other major defects	0.691	0.309	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.691	0.309	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.001	0.310	0.689
C92.0 Acute myeloid leukaemia	0.690	0.310	0.000
B37.0 Candidal stomatitis	0.689	0.311	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.689	0.311	0.000
L44.0 Pityriasis rubra pilaris	0.689	0.311	0.000
C60 Malignant neoplasm of penis	0.689	0.311	0.000
C37 Malignant neoplasm of thymus	0.688	0.311	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.688	0.312	0.000
L11 Other acantholytic disorders	0.688	0.312	0.000
M14 Arthropathies in other diseases classified elsewhere	0.487	0.312	0.201
D86.3 Sarcoidosis of skin	0.688	0.312	0.000
C86 Other specified types of T/NK-cell lymphoma	0.687	0.312	0.000
E89.0 Postprocedural hypothyroidism	0.686	0.314	0.000
K23 Disorders of oesophagus in diseases classified elsewhere	0.685	0.314	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.685	0.315	0.000
G11.9 Hereditary ataxia, unspecified	0.684	0.316	0.000
V20-V29 Motorcycle rider injured in transport accident	0.684	0.316	0.000
N18.1 Chronic kidney disease, stage 1	0.684	0.316	0.000
G51.3 Clonic hemifacial spasm	0.683	0.317	0.000
E13.8 With unspecified complications	0.682	0.318	0.000
E13.7 With multiple complications	0.682	0.318	0.000
E13.6 With other specified complications	0.682	0.318	0.000
E13.5 With peripheral circulatory complications	0.682	0.318	0.000
E13.4 With neurological complications	0.682	0.318	0.000
E13.3 With ophthalmic complications	0.682	0.318	0.000
E13.2 With renal complications	0.682	0.318	0.000
E13.1 With ketoacidosis	0.682	0.318	0.000
E13.0 With coma	0.682	0.318	0.000
G62.1 Alcoholic polyneuropathy	0.682	0.318	0.000
L10 Pemphigus	0.680	0.320	0.000
L14 Bullous disorders in diseases classified elsewhere	0.680	0.320	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.679	0.321	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.679	0.321	0.000
B37.4 Candidiasis of other urogenital sites	0.678	0.322	0.000
D73.9 Disease of spleen, unspecified	0.677	0.323	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.005	0.323	0.673
G53 Cranial nerve disorders in diseases classified elsewhere	0.677	0.323	0.000
C83.1 Small cleaved cell (diffuse)	0.676	0.323	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.676	0.324	0.000
D86.9 Sarcoidosis, unspecified	0.674	0.326	0.000
K90.3 Pancreatic steatorrhoea	0.674	0.326	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.674	0.326	0.000
K90.1 Tropical sprue	0.674	0.326	0.000
K90.0 Coeliac disease	0.674	0.326	0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.674	0.326	0.000
Q40 Other congenital malformations of upper alimentary tract	0.671	0.329	0.000
E21.4 Other specified disorders of parathyroid gland	0.670	0.330	0.000
X00-X09 Exposure to smoke, fire and flames	0.669	0.331	0.000
D81 Combined immunodeficiencies	0.668	0.332	0.000
E55 Vitamin D deficiency	0.667	0.333	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.665	0.335	0.000
E28.2 Polycystic ovarian syndrome	0.664	0.336	0.000
V90-V94 Water transport accidents	0.664	0.336	0.000
B18 Chronic viral hepatitis	0.663	0.337	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.662	0.338	0.000
D62 Acute posthaemorrhagic anaemia	0.662	0.338	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.662	0.338	0.000
E27.9 Disorder of adrenal gland, unspecified	0.661	0.338	0.000
B34 Viral infection of unspecified site	0.661	0.339	0.000
K28 Gastrojejunal ulcer	0.660	0.340	0.000
M06.8 Other specified rheumatoid arthritis	0.010	0.340	0.649
M06.2 Rheumatoid bursitis	0.010	0.340	0.649
M06.1 Adult-onset Still's disease	0.010	0.340	0.649
N02 Recurrent and persistent haematuria	0.658	0.341	0.001
A50-A64 Infections with a predominantly sexual mode of transmission	0.658	0.342	0.000
L42 Pityriasis rosea	0.658	0.342	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.342	0.657
E06 Thyroiditis	0.657	0.342	0.000
E11.4 With neurological complications	0.657	0.343	0.000
G54 Nerve root and plexus disorders	0.657	0.343	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.657	0.343	0.000
G31.8 Other specified degenerative diseases of nervous system	0.657	0.343	0.000
B25 Cytomegaloviral disease	0.657	0.343	0.000
C15 Malignant neoplasm of oesophagus	0.657	0.343	0.000
L13.9 Bullous disorder, unspecified	0.657	0.343	0.000
L13.8 Other specified bullous disorders	0.657	0.343	0.000
L13.1 Subcorneal pustular dermatitis	0.657	0.343	0.000
D00-D09 In situ neoplasms	0.657	0.343	0.000
G71.3 Mitochondrial myopathy, not elsewhere classified	0.656	0.344	0.000
G14 Postpolio syndrome	0.656	0.344	0.000
Q44.6 Cystic disease of liver	0.656	0.344	0.000
C82.6 Cutaneous follicle centre lymphoma	0.656	0.344	0.000
C82.5 Diffuse follicle centre lymphoma	0.656	0.344	0.000
C82.4 Follicular lymphoma grade IIIb	0.656	0.344	0.000
E53 Deficiency of other B group vitamins	0.656	0.344	0.000
E11.0 With coma	0.655	0.345	0.000
C92.1 Chronic myeloid leukaemia	0.655	0.345	0.000
W27 Contact with nonpowered hand tool	0.654	0.346	0.000
Q61 Cystic kidney disease	0.654	0.346	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.654	0.346	0.000
K25.6 Chronic or unspecified with both haemorrhage and perforation	0.654	0.346	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations